Panagora Asset Management Inc Imara Inc. Transaction History

Panagora Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.99 - $1.87 $11,336 - $21,413	11,451 New	11,451 $14,000
Q3 2021 Nov 10, 2021	SELL	$4.08 - $7.83 $473 - $908	-116 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$6.78 - $9.04 $40 - $54	-6 Reduced 4.92%	116 $1,000
Q4 2020 Feb 10, 2021	BUY	$15.81 - $29.0 $1,928 - $3,538	122 New	122 $3,000

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.